PharmaEngine is a networked pharma company that operates according to the "Virtual Pharmaceutical Company Business Model" model to focus on new drug development and lower related risks. PharmaEngine's main revenue source is from the selling and authorizing of our current product, ONIVYDE®. In addition, we continue to license in and take lead on multiple new drug development projects. With our extensive project management experiences, we continue to conduct clinical trials and business developments. Our goal is to become the most professional new drug development company in Asia.
